Fasken Martineau was retained by a pharmaceutical company following the rejection of a major price increase for one of its products in a number of Canadian provinces. Fasken Martineau advised on strategic approaches and negotiated with the various Ministries of Health. The price increase was ultimately accepted in most Canadian provinces.
Client Work
Pharmaceutical company is advised on strategic approaches and negotiations with the various Ministries of Health
Fasken
Reading Time
1 minute read
Overview
Overview
Team
Team
- Mathieu Gagné, Partner | Co-Leader, Life Sciences, Montréal, QC, +1 514 397 7657, mgagne@fasken.com
- Jean-Raphaël Champagne, Partner | Life Sciences, Emerging Technology & Venture Capital, Québec, QC, +1 418 640 2084, jchampagne@fasken.com
- Dara Jospé, Partner | Intellectual Property, Montréal, QC, +1 514 397 7649, djospe@fasken.com
